Industry Growth Insights published a new data on “GMP Cell Banking Services Market”. The research report is titled “GMP Cell Banking Services Market research by Types (Mammalian, Microbial, Insect, Yeast, Avian, Stem Cell, Others), By Applications (Biopharmaceutical Companies, Contract Manufacturing Organizations), By Players/Companies WuXi AppTec, Charles River Laboratories, Eurofins Scientific, Merck KGaA, Lonza, SGS Ltd, ViruSure, Austrianova, Goodwin Biotechnology, Paragon Bioservices, BioReliance, Sartorious, BSL Bioservice, Cleancells, Covance”.
Scope Of The Report
Report Attributes
Report Details
Report Title
GMP Cell Banking Services Market Research Report
By Type
Mammalian, Microbial, Insect, Yeast, Avian, Stem Cell, Others
By Application
Biopharmaceutical Companies, Contract Manufacturing Organizations
By Companies
WuXi AppTec, Charles River Laboratories, Eurofins Scientific, Merck KGaA, Lonza, SGS Ltd, ViruSure, Austrianova, Goodwin Biotechnology, Paragon Bioservices, BioReliance, Sartorious, BSL Bioservice, Cleancells, Covance
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
185
Number of Tables & Figures
130
Customization Available
Yes, the report can be customized as per your need.
Global GMP Cell Banking Services Market Report Segments:
The global GMP Cell Banking Services market is segmented on the basis of:
Types
Mammalian, Microbial, Insect, Yeast, Avian, Stem Cell, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Biopharmaceutical Companies, Contract Manufacturing Organizations
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- WuXi AppTec
- Charles River Laboratories
- Eurofins Scientific
- Merck KGaA
- Lonza
- SGS Ltd
- ViruSure
- Austrianova
- Goodwin Biotechnology
- Paragon Bioservices
- BioReliance
- Sartorious
- BSL Bioservice
- Cleancells
- Covance
Highlights of The GMP Cell Banking Services Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Mammalian
- Microbial
- Insect
- Yeast
- Avian
- Stem Cell
- Others
- By Application:
- Biopharmaceutical Companies
- Contract Manufacturing Organizations
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the GMP Cell Banking Services Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
GMP Cell Banking Services is a suite of products and services that allow banks to store, manage, and monitor their cell phone assets. GMP Cell Banking Services includes a cell phone asset management system (CMMS) that helps banks track the location, condition, and use of their cell phones. In addition to CMMS capabilities, GMP Cell Banking Services offers other features such as automated reporting and tracking of lost or stolen phones; 24/7 customer support; and the ability to remotely lock or erase phones.
Some of the key players operating in the gmp cell banking services market are WuXi AppTec, Charles River Laboratories, Eurofins Scientific, Merck KGaA, Lonza, SGS Ltd, ViruSure, Austrianova, Goodwin Biotechnology, Paragon Bioservices, BioReliance, Sartorious, BSL Bioservice, Cleancells, Covance.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 GMP Cell Banking Services Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 GMP Cell Banking Services Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 GMP Cell Banking Services Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the GMP Cell Banking Services Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global GMP Cell Banking Services Market Size & Forecast, 2018-2028
4.5.1 GMP Cell Banking Services Market Size and Y-o-Y Growth
4.5.2 GMP Cell Banking Services Market Absolute $ Opportunity
Chapter 5 Global GMP Cell Banking Services Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 GMP Cell Banking Services Market Size Forecast by Type
5.2.1 Mammalian
5.2.2 Microbial
5.2.3 Insect
5.2.4 Yeast
5.2.5 Avian
5.2.6 Stem Cell
5.2.7 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global GMP Cell Banking Services Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 GMP Cell Banking Services Market Size Forecast by Applications
6.2.1 Biopharmaceutical Companies
6.2.2 Contract Manufacturing Organizations
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global GMP Cell Banking Services Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 GMP Cell Banking Services Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America GMP Cell Banking Services Analysis and Forecast
9.1 Introduction
9.2 North America GMP Cell Banking Services Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America GMP Cell Banking Services Market Size Forecast by Type
9.6.1 Mammalian
9.6.2 Microbial
9.6.3 Insect
9.6.4 Yeast
9.6.5 Avian
9.6.6 Stem Cell
9.6.7 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America GMP Cell Banking Services Market Size Forecast by Applications
9.10.1 Biopharmaceutical Companies
9.10.2 Contract Manufacturing Organizations
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe GMP Cell Banking Services Analysis and Forecast
10.1 Introduction
10.2 Europe GMP Cell Banking Services Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe GMP Cell Banking Services Market Size Forecast by Type
10.6.1 Mammalian
10.6.2 Microbial
10.6.3 Insect
10.6.4 Yeast
10.6.5 Avian
10.6.6 Stem Cell
10.6.7 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe GMP Cell Banking Services Market Size Forecast by Applications
10.10.1 Biopharmaceutical Companies
10.10.2 Contract Manufacturing Organizations
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific GMP Cell Banking Services Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific GMP Cell Banking Services Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific GMP Cell Banking Services Market Size Forecast by Type
11.6.1 Mammalian
11.6.2 Microbial
11.6.3 Insect
11.6.4 Yeast
11.6.5 Avian
11.6.6 Stem Cell
11.6.7 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific GMP Cell Banking Services Market Size Forecast by Applications
11.10.1 Biopharmaceutical Companies
11.10.2 Contract Manufacturing Organizations
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America GMP Cell Banking Services Analysis and Forecast
12.1 Introduction
12.2 Latin America GMP Cell Banking Services Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America GMP Cell Banking Services Market Size Forecast by Type
12.6.1 Mammalian
12.6.2 Microbial
12.6.3 Insect
12.6.4 Yeast
12.6.5 Avian
12.6.6 Stem Cell
12.6.7 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America GMP Cell Banking Services Market Size Forecast by Applications
12.10.1 Biopharmaceutical Companies
12.10.2 Contract Manufacturing Organizations
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) GMP Cell Banking Services Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) GMP Cell Banking Services Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) GMP Cell Banking Services Market Size Forecast by Type
13.6.1 Mammalian
13.6.2 Microbial
13.6.3 Insect
13.6.4 Yeast
13.6.5 Avian
13.6.6 Stem Cell
13.6.7 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) GMP Cell Banking Services Market Size Forecast by Applications
13.10.1 Biopharmaceutical Companies
13.10.2 Contract Manufacturing Organizations
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 GMP Cell Banking Services Market: Competitive Dashboard
14.2 Global GMP Cell Banking Services Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 WuXi AppTec
14.3.2 Charles River Laboratories
14.3.3 Eurofins Scientific
14.3.4 Merck KGaA
14.3.5 Lonza
14.3.6 SGS Ltd
14.3.7 ViruSure
14.3.8 Austrianova
14.3.9 Goodwin Biotechnology
14.3.10 Paragon Bioservices
14.3.11 BioReliance
14.3.12 Sartorious
14.3.13 BSL Bioservice
14.3.14 Cleancells
14.3.15 Covance
